Diagnostic inconsistency of faecal immunochemical tests for haemoglobin in population screening of colorectal cancer

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 11, 2013, Pages 2173-2180

  Huang, Yanqin ^a,b   Ge, Weiting ^a,b   London, Viktoriya ^c   Li, Qilong ^d   Cai, Shanrong ^a,b   Zhang, Suzhan ^a,b   Zheng, Shu ^a,b  

^a China National Ministry of Education   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Jiashan Institute of Oncology Prevention and Treatment   (China)

Author keywords

colorectal cancer screening; faecal immunochemical test; haemoglobin; quality assurance

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; CHINA; COLOR; COLORECTAL CANCER; DENSITY; DIAGNOSTIC VALUE; FECES; FECES LEVEL; FEMALE; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; OCCULT BLOOD; PRIORITY JOURNAL; TEST STRIP;

ADULT; AGED; COLORECTAL NEOPLASMS; FECES; HEMOGLOBINS; HUMANS; IMMUNOCHEMISTRY; MASS SCREENING; MIDDLE AGED; REPRODUCIBILITY OF RESULTS;

EID: 84886685806     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2013-0232     Document Type: Article

References (31)

1. Rosman AS, Korsten MA. Effect of verification bias on the sensitivity of fecal occult blood testing: A meta-Analysis. J Gen Intern Med 2010;25:1211-21
2. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008;58:130-60
3. Cole SR, Young GP, Esterman A, Cadd B, Morcom J. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen 2003;10:117-22
4. Hol L, De Jonge V, van Leerdam ME, van Ballegooijen M, Looman CW, van Vuuren AJ, et al. Screening for colorectal cancer: Comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy. Eur J Cancer 2010;46:2059-66
5. Allison JE. The role of fecal occult blood testing in screening for colorectal cancer. Pract Gastroenterol 2007;Colorectal Cancer: An Update for Diagnosis and Prevention Series #3:20-32
6. Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996;334:155-9
7. Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, et al. Screening for colorectal neoplasms with new fecal occult blood tests: Update on performance characteristics. J Natl Cancer Inst 2007;99:1462-70
8. Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC, et al. Screening for colorectal cancer: Randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010;59:62-8
9. van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;135:82-90
10. Parra-Blanco A, Gimeno-Garcia AZ, Quintero E, Nicolas D, Moreno SG, Jimenez A, et al. Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening. J Gastroenterol 2010;45:703-12
11. van Rossum LG, van Rijn AF, Verbeek AL, van Oijen MG, Laheij RJ, Fockens P, et al. Colorectal cancer screening comparing no screening, immunochemical and guaiac fecal occult blood tests: A cost-effectiveness analysis. Int J Cancer 2011;128:1908-17
12. Hol L, Wilschut JA, van Ballegooijen M, van Vuuren AJ, van der Valk H, Reijerink JC, et al. Screening for colorectal cancer: Random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer 2009;100:1103-10
13. Berchi C, Guittet L, Bouvier V, Launoy G. Cost-effectiveness analysis of the optimal threshold of an automated immuno chemical test for colorectal cancer screening: Performances of immunochemical colorectal cancer screening. Int J Technol Assess Health Care 2010;26:48-53
14. Dancourt V, Lejeune C, Lepage C, Gailliard MC, Meny B, Faivre J. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms. Eur J Cancer 2008;44:2254-8
15. Hundt S, Haug U, Brenner H. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med 2009;150:162-9
16. Brenner H, Haug U, Hundt S. Inter-Test agreement and quantitative cross-validation of immunochromatographical fecal occult blood tests. Int J Cancer 2010;127:1643-9
17. Imperiale TF. Noninvasive screening tests for colorectal cancer. Dig Dis 2012;30(Suppl 2):16-26
18. Fraser CG, Allison JE, Halloran SP, Young GP, Expert Working Group on Fecal Immunochemical Tests for Hemoglobin CCSCWEO. A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin. J Natl Cancer Inst 2012;104:810-4
19. Fraser CG. A future for faecal haemoglobin measurements in the medical laboratory. Ann Clin Bio Chem 2012;49: 518-26
20. Rozen P, Comaneshter D, Levi Z, Hazazi R, Vilkin A, Maoz E, et al. Cumulative evaluation of a quantitative immunochemical fecal occult blood test to determine its optimal clinical use. Cancer 2010;116:2115-25
21. Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005;129:422-8
22. Li S, Wang H, Hu J, Li N, Liu Y, Wu Z, et al. New immunochemical fecal occult blood test with two-consecutive stool sample testing is a cost-effective approach for colon cancer screening: Results of a prospective multicenter study in Chinese patients. Int J Cancer 2006;118:3078-83
23. Cai SR, Zhang SZ, Zhu HH, Huang YQ, Li QR, Ma XY, et al. Performance of a colorectal cancer screening protocol in an economically and medically underserved population. Cancer Prev Res (Phila) 2011;4:1572-9
24. Halloran SP, Launoy G, Zappa M. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition-Faecal occult blood testing. Endoscopy 2012;44(Suppl 3):SE65-87
25. van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, Jansen JB, et al. Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme. Br J Cancer 2009;101:1274-81
26. Terhaar sive Droste JS, Oort FA, van der Hulst RW, van Heukelem HA, Loffeld RJ, van Turenhout ST, et al. Higher fecal immunochemical test cutoff levels: Lower positivity rates but still acceptable detection rates for early-stage colorectal cancers. Cancer Epidemiol Biomarkers Prev 2011;20:272-80
27. Wong BC, Wong WM, Cheung KL, Tong TS, Rozen P, Young GP, et al. A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population. Aliment Pharmacol Ther 2003;18:941-6
28. Cha JM, Lee JI, Joo KR, Shin HP, Park JJ, Jeun JW, et al. Performance of the fecal immunochemical test is not decreased by high ambient temperature in the rapid return system. Dig Dis Sci 2012;57:2178-83
29. Grazzini G, Ventura L, Zappa M, Ciatto S, Confortini M, Rapi S, et al. Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: Observational study from the Florence district. Gut 2010;59:1511-5
30. van Roon AH, Hol L, van Vuuren AJ, Francke J, Ouwendijk M, Heijens A, et al. Are fecal immunochemical test characteristics influenced by sample return time? A population-based colorectal cancer screening trial. Am J Gastroenterol 2012;107:99-107
31. Noboru Goto MF, Ito K, Tanaka M, Ohara S, Makise J, Kijima Y. Basic study of OC-SENSOR, a compact fully automated immunochemistry analyzer for fecal occult blood tests. J Clin Lab Instruments Reagents 2002;25:57-62